Menu
Your Cart

News

Apr 12, 2021

Apostle RNA Extraction Method is Included in a US FDA EUA Authorized SARS-CoV-2 Molecular Diagnostic Test: Fulgent COVID-19 by RT-PCT Test

Apostle Inc is pleased to announce that the company’s Apostle RNA Extraction Method is included in the recent US FDA EUA authorization of a SARS-CoV-2 Molecular Diagnostic Test: Fulgent COVID-19 by RT-PCT Test, as reagent and system used with the FDA EUA authorized test.      ....read more

Feb 2, 2021

Apostle MiniMax Technology In Novel Liquid Biopsy Method for Detecting and Monitoring Colon Cancer, Published in PNAS

Apostle Inc is pleased to announce that the company’s Apostle MiniMax technology is used in the recent development of a novel liquid biopsy method for efficient detection and post-surgical monitoring of colon cancer, capable of quantitative analysis of plasma samples with as little as 0.05% tumor DNA, published in PNAS.      ....read more

Oct 1, 2020

Apostle Inc Releases an Application Note on the Apostle COVID-19 Viral RNA Extraction System

Apostle Inc is pleased to release an Application Note on the Apostle COVID-19 Viral RNA Extraction System, applied in the effective detection of SARS-CoV-2 in over 1 million clinical samples by our clients. Using Apostle system, limit of Detection (LoD) of the downstream detection system of our customer is documented at 3.6 NDU/uL published on the FDA website. The sensitivity and specificity is 99.9% and 99.9% at 3 copies/uL, respectively, published on our customer’s website.  ....read more

Sept 7, 2020

Apostle Inc’s MiniEnrich Technology is Published at Royal Society of Chemistry’s Analyst

Apostle Inc is pleased to announce that the company’s original technology, termed the Apostle MiniEnrich Technology, is published at Royal Society of Chemistry’s Analyst on Sept 7, 2020, vol 145, issue 17, pp 5733-5739, and is selected as the inside front cover story.   ....read more

Sept 3, 2020

Apostle Inc Appoints Charles (Buck) Strom to Board of Advisors

Apostle Inc is pleased to announce the appointment of Charles (Buck) Strom, MD, PhD, FAAP, FACMG, HCLD, as a new member to its Board of Advisors.   ....read more

Feb 13, 2020

Apostle Inc to Present at the 5th Annual Liquid Biopsy Summit

Apostle Inc is pleased to announce that the company is going to present at the 5th Liquid Biopsy Summit, to take place in Seattle, WA on June 15-17, 2020. David Ge, CEO of Apostle, will discuss Apostle MiniEnrich, a novel method for enrichment of short DNA fragments for NIPT and oncology applications.   ....read more

Jan 27, 2020

Apostle Inc Appoints Antonius ‘Toni’ Schuh to Board of Advisors

Apostle Inc is pleased to announce the appointment of Antonius ‘Toni’ Schuh, PhD - a successful serial entrepreneur and founder in the life sciences industries as CEOs of 5 companies with 3 IPOs - as a new member to its Board of Advisors.    ....read more

Jan 23, 2020

Apostle Inc Presents at the PMWC 2020

Apostle Inc presents at the Precision Medicine World Conference 2020 held in Santa Clara, California.   ....read more

Jan 15, 2020

Apostle Inc Appoints Eric D. Masingale as VP of Business Operations

Apostle Inc is pleased to announce the appointment of Mr. Eric D. Masingale as its Vice President of Business Operations.   ....read more

May 24, 2019

Apostle Inc Completes Series A Financing Led by ShangBay Capital

Apostle Inc is pleased to announce the completion of its series A financing.   ....read more

Apr 16, 2019

Apostle Inc Obtains ISO13485:2016 & ISO9001:2015 Certification

Apostle Inc is pleased to receive the Certificates of Conformance to certify its Quality Management System.    ....read more

Feb 28, 2019

Apostle Inc. Enters Partnership with Beckman Coulter Life Sciences

Apostle Inc is pleased to announce an exclusive partnership with Beckman Coulter, a world leader in Life Sciences, for Apostle MiniMax(TM) High Efficiency Cell-Free DNA Isolation Kit.    ....read more

Sept 28, 2018

Apostle's China Manufacturing Facility Obtains ISO9001:2015 Certification

Apostle's manufacturing facility located in Shenzhen, China obtains ISO9001:2015 certification.     ....read more

Apr 3, 2018

Apostle is Elected into the Stanford University StartX Accelerator Program (Summer 2018 session)

Apostle is elected into the StartX Accelerator Program (Summer 2018 session), one of the most pretigeous accelerator programs in the Silicon Valley.     ....read more

Feb 12, 2018

Apostle Inc Appoints Alexander Hartemink, PhD at Duke University to Scientific Advisory Board

Apostle Inc is pleased to announce the appointment of Alexander J. Hartemink, PhD as a new member to its Scientific Advisory Board.     ....read more

Jan 31, 2018

Apostle Inc Appoints David B. Goldstein, PhD at Columbia University to Scientific Advisory Board

Apostle Inc is pleased to announce the appointment of David B. Goldstein, PhD as a new member to its Scientific Advisory Board.    ....read more

Sept 1, 2017

Apostle Inc Appoints Director of Oncology Research at Stanford University to Scientific Advisory Board

Apostle Inc is pleased to announce the appointment of Dean W. Felsher, MD, PhD as a new member to its Scientific Advisory Board. Dr. Felsher is Professor of Medicine in Departments of Oncology and Pathology at Stanford University School of Medicine. He is Director of Stanford Translational Research and Applied Medicine (TRAM) as well as Director of Oncology Research, Division of Oncology at Stanford.    ....read more

Jun 16, 2017

Apostle Announces New Board Member And Advisors

Apostle Inc is pleased to announce the appointment of William Dai, MBA as a new member to its Board of Directors, and Charles Cantor, PhD and Hongyu Zhao, PhD as new members to its Advisory Board.   ....read more

Mar 28, 2017

Apostle Inc is Founded

Apostle Inc, a biotechnology company focusing on liquid biopsy, is founded in the Silicon Valley.   ....read more